DavidGuyKirschMD
Radiation Oncology • Durham, NCAssociate Professor, Radiation Oncology, Duke University School of Medicine
Dr. Kirsch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2001 - 2005
Greater Baltimore Medical CenterInternship, Internal Medicine, 2000 - 2001
Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
NC State Medical License 2007 - 2023
MA State Medical License 2005 - 2007
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg Start of enrollment: 2008 Mar 01
Publications & Presentations
PubMed
- FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy.Haiwei Ni, Zachary J Reitman, Wei Zou, Md Naushad Akhtar, Ritama Paul
Nature Cancer. 2025-02-05 - Response to Central Boost Radiation Therapy in Unresectable Retroperitoneal Sarcoma: A Case Series.Danielle N Burner, Peter G Hendrickson, Diana M Cardona, Dan G Blazer 3rd, James B Mullins
Advances in Radiation Oncology. 2025-02-01 - Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC...Yvonne M Mowery, Karla V Ballman, Angela M Hong, Scott M Schuetze, Andrew J Wagner
Lancet. 2024-11-23
Other
- Pathogenetic factors in soft tissue and bone sarcomasKirsch DG, DeLaney TF
http://www.uptodate.com/contents/pathogenetic-factors-in-soft-tissue-and-bone-sarcomas
UpToDate, Wolters Kluwer Health - 2013-02-19
Press Mentions
Pembrolizumab, an Immunotherapy Medication, Improves Outcomes for Patients with Soft Tissue SarcomaNovember 14th, 2024- Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free SurvivalNovember 13th, 2024
NIH Awards $1.4M for Radiology, Oncology Resident Research InitiativeFebruary 18th, 2020- Join now to see all
Grant Support
- Independent Scientist Award For Radiation ResearchNational Institute Of Allergy And Infectious Diseases2011–2012
- Mechanisms Of LATE Effects Of Exposure To RadiationNational Institute Of Allergy And Infectious Diseases2008–2011
- Dissecting Mechanisms Of Metastasis Through Comparative Systems GeneticsNational Cancer Institute2008–2011
- Imaging Lung Cancer In Mice To Improve Radiation TherapyNational Center For Research Resources2008–2010
- Quantitative Preclinical Tumor Imaging Using Micro-CtNational Center For Research Resources2009
- Image-Guided Radiation Therapy And Radiosurgery For Small AnimalsNational Center For Research Resources2009
- Dissecting The Mechanism Of The GI Syndrome To Restore GI Function After RadiatioNational Institute Of Allergy And Infectious Diseases2007–2009
- Imaging Lung Cancer In Mice To Improve Radiation TherapyNational Cancer Institute2007–2009
- Imaging Lung Cancer In Mice To Improve Radiation TherapyNational Cancer Institute2005–2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
